---
$id: https://graph.org.ai/products/commodity/51351618
$type: Product
source: UNSPSC
code: "51351618"
title: "Ormeloxifene or centchroman"
class: "51351600"
classTitle: "Estrogen, progestin, or internal contraceptive estrenes"
family: "51350000"
familyTitle: "Estrogens and progestins and internal contraceptives"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ormeloxifene or centchroman

**UNSPSC Code**: 51351618
**Class**: [Estrogen, progestin, or internal contraceptive estrenes](Estrogen, progestin, or internal contraceptive estrenes.mdx)
**Family**: [Estrogens and progestins and internal contraceptives](../Estrogens and progestins and internal contraceptives.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiestrogen with the molecular formula C30H35NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 44AXY5VE90, chemically known as 3,4-trans-2,2-dimethyl-3-phenyl-4-(p-(beta-pyrrolidinoethoxy)phenyl)-7-methoxychroman but generally known as ormeloxifene, which bears US NIH Compound Identifier 35805. European Medicines Agency schedules Ormeloxifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09462MIG. The term ORMELOXIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). ORMELOXIFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Ormeloxifene or centchroman bears US NLM identifiers UMLS ID C1701687 and NCI Concept Code C90722. SMILES: O1C(C(C(C2C1CC(OC)CC2)C1CCC(OCCN2CCCC2)CC1)C1CCCCC1)(C)C.

